Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 15.08 is 13% below its 2-year average of 17.32, around the middle of its 2-year range (0.00–47.60).
As of the fiscal period ended Tuesday, June 30, 2026. 47.49% below its 12-month average of 28.72.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 15.08.
CURRENT RATIO
15.08
CURRENT RATIO AVG TTM
28.72
CURRENT RATIO AVG 3Y
N/A
CURRENT RATIO AVG 5Y
N/A
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-47.49%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.75
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+302.08%
vs the sector median at left
LB Pharmaceuticals Inc Common Stock
Market Cap
$978.73M
Current Ratio
15.08
TTM Avg
28.72
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$981.10M
Current Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$969.12M
Current Ratio
5.04
TTM Avg
3.47
3Y Avg
3.89
5Y Avg
3.30
Market Cap
$992.10M
Current Ratio
6.55
TTM Avg
7.96
3Y Avg
7.82
5Y Avg
9.82
Market Cap
$998.69M
Current Ratio
8.42
TTM Avg
11.89
3Y Avg
15.48
5Y Avg
17.00
Market Cap
$953.01M
Current Ratio
16.33
TTM Avg
11.68
3Y Avg
16.13
5Y Avg
16.13
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| LB Pharmaceuticals Inc Common Stock (LBRX) | $978.73M | 15.08 | 28.72 | N/A | N/A |
| Latigo Biotherapeutics Inc. (LTGO)vs › | $981.10M | N/A | N/A | N/A | N/A |
| MeiraGTx Holdings plc (MGTX)vs › | $976.80M | 3.76 | 1.39 | 1.76 | 2.46 |
| Pacira BioSciences, Inc. (PCRX)vs › | $969.12M | 5.04 | 3.47 | 3.89 | 3.30 |
| PROCEPT BioRobotics Corporation (PRCT)vs › | $992.10M | 6.55 | 7.96 | 7.82 | 9.82 |
| Vor Biopharma Inc. (VOR)vs › | $992.39M | 19.15 | 11.70 | 12.62 | 12.74 |
| Savara Inc. (SVRA)vs › | $951.89M | 10.13 | 12.79 | 15.81 | 14.15 |
| Cullinan Therapeutics, Inc. (CGEM)vs › | $998.69M | 8.42 | 11.89 | 15.48 | 17.00 |
| Aktis Oncology, Inc. (AKTS)vs › | $953.01M | 16.33 | 11.68 | 16.13 | 16.13 |
| Immatics N.V. (IMTX)vs › | $1.01B | 7.54 | 10.49 | 6.85 | 5.34 |
Current Ratio
15.08
Quick Ratio
15.08
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 15.08 |
| 2026-03-31 | 35.68 |
| 2025-12-31 | 41.44 |
| 2025-09-30 | 47.60 |
| 2025-06-30 | 3.78 |
| 2025-03-31 | 3.78 |
| 2024-09-30 | 0.00 |
| 2024-06-30 | 0.00 |
| 2024-03-31 | 8.55 |
